These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 2854727

  • 1. Effect of derivatives of trapidil on the expression of LDL receptors.
    Beitz J, Corsini A, Granata A, Fumagalli R, Mest HJ, Paoletti R.
    Biomed Biochim Acta; 1988; 47(10-11):S153-6. PubMed ID: 2854727
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Regulation of low-density lipoprotein receptors in the human hepatoma cell line Hep G2.
    Illingworth DD, Lindsey S, Hagemenas FC.
    Exp Cell Res; 1984 Dec; 155(2):518-26. PubMed ID: 6094224
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of cytosolic Ca++ mobilization in human platelets by the antianginal drug trapidil and its derivative AR 12463.
    Block HU, Gabbasov ZA, Pozin EY, Popov EG, Mest HJ.
    Biomed Biochim Acta; 1988 Dec; 47(12):1093-7. PubMed ID: 2855396
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Trapidil and other 5-triazolo-(1, 5-alpha)-pyrimidine derivatives as calcium channel blockers in 108CC5 cells.
    Hering S, Bodewei R, Schubert B, Krause EG, Wollenberger A.
    Biomed Biochim Acta; 1985 Dec; 44(5):K37-41. PubMed ID: 2415119
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Trapidil derivatives as potential antiatherosclerotic drugs.
    Giessler C, Fahr A, Tertov VV, Kudryashov SA, Orekhov AN, Smirnov VN, Mest HJ.
    Arzneimittelforschung; 1987 May; 37(5):538-41. PubMed ID: 3040019
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of thromboxane A2 production by trapidil and trapidil derivatives in the arachidonic acid-injected rat.
    Heinroth-Hoffmann I, Hauser A, Mest HJ.
    Prostaglandins Leukot Med; 1987 Dec; 30(2-3):87-92. PubMed ID: 2827194
    [Abstract] [Full Text] [Related]

  • 17. The metabolism in vitro of human low-density lipoprotein by the human hepatoma cell line Hep G2.
    Havekes L, van Hinsbergh V, Kempen HJ, Emeis J.
    Biochem J; 1983 Sep 15; 214(3):951-8. PubMed ID: 6312967
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Trapidil derivatives as potent inhibitors of cyclic AMP phosphodiesterase from heart and coronary arteries.
    Bartel S, Tenor H, Krause EG.
    Biomed Biochim Acta; 1985 Sep 15; 44(5):K31-5. PubMed ID: 2415118
    [Abstract] [Full Text] [Related]

  • 20. Influence of drugs on the TXA2/PGI2 balance and on the atherogenic index in myocardial ischemia in dogs.
    Beitz A, Taube C, Beitz J, Goos H, Graff J, Nohring J, Lindenau KF, Mest HJ.
    Biomed Biochim Acta; 1988 Sep 15; 47(10-11):S149-52. PubMed ID: 2470353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.